heidykhlaaf.bsky.social
Climber 🇪🇬 |Chief AI Scientist at @ainowinstitute.bsky.social | Safety engineer (nuclear, defense, software & AI/ML) | TIME 100 AI | MIT 35 U 35 x-Trail of Bits, OpenAI, Microsoft Research https://www.heidyk.com/
👤 Joined on 22 June 2023
Followers
Following
Total Posts
@heidykhlaaf.bsky.socialhistoftech.bsky.social
icegov.bsky.social
Not Found
romanpalace.bsky.social
oponiak.bsky.social
keybyss.bsky.social
markhamillofficial.bsky.social
barackobama.bsky.social
danmk.bsky.social
Not Found
jessesingal.com
yoavgo.bsky.social
Not Found
walshfreedom.bsky.social
officialbenshapiro.bsky.social
henmazzig.bsky.social
Not Found
taliaringer.bsky.social
Not Found
pockets6794.bsky.social
brentwaggoner.bsky.social
ozmodiar.bsky.social
wendelschwab.bsky.social
canglong333.bsky.social
riotwomennn.bsky.social
Former FTC Chair @linamkhan.bsky.social will be in conversation with author @anandwrites.bsky.social about how we govern AI and rein in the growing power of the tech industry. Join us & @moreperfectunion.bsky.social on Mon, Oct. 19th at Webster Hall or tune in to the livestream: bit.ly/ai-assembly
Show PostNYC Mayor (@mayor.nyc.gov) Zohran Mamdani will be in convo with comedian, artist, and activist Ilana Glazer about how everyday people can reassert control over AI’s impact on our lives and our collective futures. Join us on Mon, 10/19 at Webster Hall or tune in to the livestream: bit.ly/ai-assembly
Show PostAuthors Naomi Klein (@naomiaklein.bsky.social) and Arundhati Roy will be in conversation with Karen Hao (@karenhao.bsky.social) about art, AI, and imagining another world and future for us all. Tune in to the livestream on Monday 10/19 at 7pm ET! Register at bit.ly/ai-assembly
Show PostAI agents aren’t ‘going rogue.’ Frontier labs are skipping security basics. > Compounding the problem, according to a half dozen cybersecurity experts CSO interviewed at three industry conferences in September and in subsequent conversations, is that ...
Show PostThere are a lot of validity issues with these benchmarks, which should be interpreted as favorable conditions. Even so, it's clear that OpenEvidence is not a reliable source. Is it good that clinicians are relying on this product outside of their expertise?
Show Post